The law of diminishing returns in clinical medicine: How much risk reduction is enough?

Abstract

The law of diminishing returns provides a critical framework for evaluating risk-reduction strategies in clinical medicine. When multiple interventions are applied to mitigate the risk of a single adverse event, the absolute risk reduction achieved by each successive measure is mathematically constrained by the preceding ones. As the baseline risk decreases, the marginal benefit of additional treatments approaches zero. This decline in value is frequently compounded by the linear increase in side effects and the exponential rise in potential drug-drug and drug-disease interactions associated with polypharmacy. Furthermore, because many interventions function through overlapping physiological pathways, their effects are often duplicative rather than additive. Quantitative simulations suggest that a small number of high-impact interventions typically capture the vast majority of achievable risk reduction. Consequently, clinical practice should prioritize a limited selection of patient-centered, high-value interventions rather than pursuing exhaustive adherence to all available guidelines. This shift underscores the necessity for comparative effectiveness research and decision-support tools that rank interventions by their marginal impact on patient outcomes. Adopting this framework facilitates a more rational approach to cost containment and minimizes the potential for medical harm associated with pursuing marginal therapeutic gains. – AI-generated abstract.